Coffee is among the most consistently health-associated beverages, most strongly linked to longer life and lower risk of type 2 diabetes and liver disease, with likely heart, Parkinson's, and mood benefits. Decaffeinated retains much of this. Benefits peak at a moderate few cups daily; late, unfiltered, or sugary coffee erodes them. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Blood pressure | <120/80 mmHg | Detects sensitivity to caffeine's pressor effect |
| LDL cholesterol | <100 mg/dL (2.6 mmol/L); lower if high cardiovascular risk | Flags the effect of unfiltered coffee's diterpenes |
| Fasting glucose / HbA1c | Glucose 70–90 mg/dL; HbA1c <5.4% | Tracks the metabolic benefit for diabetes risk |
| Resting heart rate | 50–70 bpm | Detects excess stimulation from high intake |
| Ferritin / iron studies | Ferritin ~50–150 ng/mL | Monitors coffee's reduction of iron absorption |
| ALT (liver enzyme) | <25 U/L (women), <30 U/L (men) | Contextualizes coffee's liver-protective association |
Cadence: Baseline before establishing regular intake, then every 6–12 months, or roughly 4–8 weeks after changing intake or brewing method